Literature DB >> 1253636

Effect of trimethoprim on the occurrence of drug-resistant coliform bacteria in the faecal flora.

A Toivanen, A Kasan, H Sundquist, P Toivanen.   

Abstract

The occurrence of drug-resistant coliform bacteria was studied in the faecal flora of 30 persons receiving for 3 weeks either trimethoprim alone, a combination of sulphamethoxazole and trimethoprim, or a combination of sulphamethoxydiazine and sulphamethoxazole. Bacterial sensitivity was tested against trimethoprim, sulphamethoxazole-trimethoprim, sulphamethoxazole, and sulphaisodimidine. After treatment with trimethoprim alone, no increase in the occurrence of strains resistant to either trimethoprim or sulphonamides was observed. After treatment with sulphamethoxazole-trimethoprim, the faecal flora contained an increased percentage of sulphonamide-resistant coliforms but significantly less than found after treatment with sulphamethoxydiazine-sulphamethoxazole. In the persons receiving the sulphonamides only, a rapid increase in sulphonamide-resistant coliforms was observed. During the whole study, only one trimethoprim-resistant coliform strain was detected.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1253636     DOI: 10.1159/000221918

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  10 in total

1.  General survey of trimethoprim combinations in the treatment of urinary tract infections.

Authors:  W Brumfitt; J M Hamilton-Miller
Journal:  Infection       Date:  1979       Impact factor: 3.553

2.  Bacterial resistance to trimethoprim.

Authors: 
Journal:  Br Med J       Date:  1980-08-30

Review 3.  Trimethoprim: a review of its antibacterial activity, pharmacokinetics and therapeutic use in urinary tract infections.

Authors:  R N Brogden; A A Carmine; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-06       Impact factor: 9.546

4.  Resistance among fecal flora of patients taking sulfamethoxazole-trimethoprim or trimethoprim alone.

Authors:  R L Guerrant; S J Wood; L Krongaard; R A Reid; R H Hodge
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

5.  Long-term low-dose co-trimoxazole in prophylaxis of childhood urinary tract infection: bacteriological aspects.

Authors:  R N Grüneberg; J M Smellie; A Leakey; W S Atkin
Journal:  Br Med J       Date:  1976-07-24

6.  Comparative trial of trimethoprim and co-trimoxazole in recurrent urinary infections.

Authors:  W Brumfitt; J M Hamilton-Miller; H Ludlam; V Damjanovic; R Gargan
Journal:  Infection       Date:  1982 Sep-Oct       Impact factor: 3.553

7.  Emergence of trimethoprim resistance in fecal flora.

Authors:  P Huovinen; T Mattila; O Kiminki; L Pulkkinen; S Huovinen; M Koskela; R Sunila; P Toivanen
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

8.  Trimethoprim resistance in Finland after five years' use of plain trimethoprim.

Authors:  P Huovinen; P Toivanen
Journal:  Br Med J       Date:  1980-01-12

9.  Effect of trimethoprim and trimethoprim-sulfamethoxazole on development of drug-resistant vaginal and fecal floras.

Authors:  S J Pancoast; D M Hyams; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

Review 10.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.